Business Context and Reporting Period
This Form 6-K is filed by Midatech Pharma PLC (noted as Biodexa Pharmaceuticals Plc in request metadata) for the month of September 2019. The filing incorporates by reference a press release dated September 30, 2019, detailing interim results for the six months ended June 30, 2019.
Key Financial Metrics
The provided text serves as a cover sheet and exhibit index. It does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document.
Material Changes
The filing text does not provide specific comparative financial data or details regarding material changes versus prior periods. It only references the existence of an interim results press release.
Guidance, Outlook, and Risks
No management commentary, guidance, outlook, risks, contingencies, or unusual items are detailed in the provided text. The document solely confirms the submission of the interim results press release as Exhibit 99.1.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for Midatech Pharma PLC, though the request metadata lists "Biodexa Pharmaceuticals Plc."
- Locate and review Exhibit 99.1 (the press release) to obtain actual financial figures for the six months ended June 30, 2019.
- Confirm the reporting period covered by the attached press release (H1 2019) versus the filing date (September 2019).